NCT03649555

Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to understand the reliability of \[18F\]-FTC-146 brain uptake in healthy controls.

Detailed description

The purpose of this study is to understand the reliability of \[18F\]-FTC-146 brain uptake in healthy controls under test and retest conditions.

Conditions

• Healthy Controls

Interventions

Type	Name	Description
DRUG	[18F]-FTC-146	Two 5 mCi \[18F\]-FTC-146 doses will be administered intravenously on two separate scan days at least one week apart (total per study = 10 mCi) Participants who complete both test days will receive 10 mCi total dose; however, if a participant is unable to return for a second test day due to unforeseen circumstances, they will receive 5 mCi total dose.

Timeline

• Start date: 2019-02-01
• Primary completion: 2020-03-03
• Completion: 2021-03-03
• First posted: 2018-08-28
• Last updated: 2025-09-10

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study